DIABIO — Diagonal Bio AB Balance Sheet
0.000.00%
- SEK14.02m
- SEK12.29m
- SEK0.02m
Annual balance sheet for Diagonal Bio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 3.67 | 20.8 | 13.6 | 2.97 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.295 | 0.466 | 0.68 | 0.523 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 4 | 21.4 | 14.5 | 4.73 |
Net Property, Plant And Equipment | — | — | — | 0.021 |
Net Intangible Assets | ||||
Total Assets | 9.97 | 36 | 34 | 28.5 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.08 | 2.14 | 2.78 | 7.26 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 1.08 | 2.14 | 2.78 | 7.26 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 8.89 | 33.9 | 31.3 | 21.2 |
Total Liabilities & Shareholders' Equity | 9.97 | 36 | 34 | 28.5 |
Total Common Shares Outstanding |